Gideon Capital Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-7,141
Closed -$361K 32
2019
Q4
$361K Buy
+7,141
New +$369K 0.12% 199
2019
Q1
Sell
-8,027
Closed -$358K 389
2018
Q4
$358K Buy
8,027
+3,428
+75% +$179K 0.15% 218
2018
Q3
$248K Buy
+4,599
New +$235K 0.12% 275
2018
Q2
Sell
-4,565
Closed -$286K 374
2018
Q1
$286K Sell
4,565
-1,238
-21% -$84.9K 0.18% 256
2017
Q4
$356K Buy
+5,803
New +$359K 0.31% 106
2017
Q2
Sell
-2,851
Closed -$232K 265
2017
Q1
$232K Sell
2,851
-1,984
-41% -$156K 0.14% 331
2016
Q4
$348K Buy
+4,835
New +$350K 0.22% 203
2015
Q3
Sell
-4,600
Closed -$385K 230
2015
Q2
$385K Buy
+4,600
New +$406K 0.16% 169
2014
Q3
Sell
-12,840
Closed -$880K 276
2014
Q2
$880K Buy
12,840
+9,418
+275% +$641K 0.32% 101
2014
Q1
$239K Buy
+3,422
New +$238K 0.13% 175

Other funds holding CAH

Gideon Capital Advisors's CAH Position: Q1 2020 in Review

Gideon Capital Advisors sold out of Cardinal Health (CAH) in Q1 2020, closing a stake of 7,141 shares — an estimated $361K sold.

Gideon Capital Advisors first reported a position in CAH in Q1 2014 and held it in 10 quarters. The position peaked at $880K in Q2 2014. 722 funds tracked by Wall St. Rank hold CAH as of Q1 2020.

  • Gideon Capital Advisors reported no remaining Cardinal Health position as of Q1 2020 after selling out during the quarter.
  • Gideon Capital Advisors sold 7,141 Cardinal Health shares in Q1 2020, an estimated $361K.
  • Gideon Capital Advisors first reported a position in Cardinal Health in Q1 2014 and held it in 10 quarters.
  • Gideon Capital Advisors's Cardinal Health position peaked at $880K in Q2 2014.
  • 722 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2020.

Based on Gideon Capital Advisors's 13F filing for Q1 2020.